Image Source: TM Editors’ note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.Vital KSK Holdings Inc. () is engaged in the distribution of pharmaceutical products and services. It operates through two segments: Pharmaceutical Wholesale and Other.The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners.The Other segment retails pharmaceutical products, wholesales agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies.All the business activity of the group is primarily focused on Japan as well as Korean and overseas markets.Vital KSK Holdings, Inc. was incorporated in 2009 and is headquartered in Setagaya, Japan.Three key data points gauge Vital KSK or any dividend-paying firm.The key three are:(1) Price(2) Dividends(3) ReturnsThose three keys also best tell whether any company has made, is making, and will make money.VKSKF PriceOver the past year, Vital KSK’s share price held steady at $7.02 as of Thursday’s market close. In the past three years, the company’s share price has never been less than $4.95 nor higher than $7.02.If Vital KSK shares trade in the range of $5.00 to $8.00 this next year, the recent $7.02 share price might reach $7.50 in a year. Of course, VKSKF price could also drop about the same $0.48 estimated amount or more.My $0.48 upside estimate is based on past VKSKF price action from 2022 to 2023.VKSKF DividendVital KSK Holdings has paid variable semi-annual dividends since May 2022. The most recent $0.15 SA dividend was declared on May 12, 2023, for shareholders of record on March 28, 2024, and it was paid on June 5th. A forward-looking $0.30 annual dividend would yield 4.33% at Thursday’s closing price. a second dividend for 2024 has not been declared.VKSKF ReturnsPutting it all together, a $0.78 estimated one-year gross gain per share shows up when adding Vital KSK’s $0.30 annual dividend to the estimated price upside of $0.48, making that $0.78 gross gain per share total.A little under $1000 buys us 142 shares at the $7.02 share price.A $10 broker fee (if charged), paid half at purchase and half at sale, might take about $0.07 per share out of the $0.78 annual estimated gross-gain to give us a net gain of $0.71 X 142 shares = $100.82 for about a 10% estimated net gain for the year.Furthermore, the $43.30 annual dividend income from $1K invested is over 6 times more than the $7.02 share price. By these numbers, VKSKF may be an ideal dividend dog at this time.Thus, you might choose to pounce on VKSKF It is a 15-year-old semi-annual variable dividend-paying Japan-based pharmaceuticals and medical services distributor with a 2-year record paying variable SA dividends.The exact track of VKSKF’s future price and dividend will entirely be determined by market action.Remember the true value of any stock is best realized through personal ownership of shares.More By This Author:
Current Report: Vital KSK
